| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $21K | — |
| SG&A Expense | $5.6M | +42.2% |
| Operating Income | -$10.3M | -29.0% |
| Interest Expense | $147K | -93.3% |
| Pre-tax Income | -$10.4M | -3.1% |
| Income Tax | -$22K | — |
| Net Income | -$10.4M | +19.0% |
| EPS (Basic) | -$0.05 | +37.5% |
| EPS (Diluted) | -$0.05 | +37.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | -65.1% |
| Accounts Receivable | $6.6M | +0.0% |
| Current Assets | $2.2M | -66.8% |
| Total Assets | $7.9M | -49.5% |
| Current Liabilities | $1.3M | -31.6% |
| Total Liabilities | $3.3M | +59.7% |
| Stockholders' Equity | $4.6M | -66.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.8M | +14.9% |
| Capital Expenditures | $301K | +33.7% |
| Investing Cash Flow | -$1.0M | +63.7% |
| Financing Cash Flow | $2.0M | -85.3% |
| Free Cash Flow | -$5.1M | +13.0% |